P. Blanchette

A survey of factor prophylaxis in the Canadian haemophilia A population

S. Israels, V. Blanchette, G. Rivard, 2004, Haemophilia.

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial

Kelly A. Fusco, Maria Cristina Lopes, D. Devine, 2021, Nature Medicine.

Pathophysiology of Levodopa-Induced Dyskinesia: Changing Concepts

M. Filion, P. Bédard, P. Blanchette, 1994 .

Primate Models of Parkinson’s Disease

P. Bédard, B. Gomez-Mancilla, R. Boucher, 1992 .

Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys.

P. Bédard, B. Gomez-Mancilla, P. Falardeau, 1993, Advances in neurology.

Levodopa-Induced Dyskinesia: Facts and Fancy. What Does the MPTP Monkey Model Tell Us?

T. Di Paolo, P. Bédard, C. Gagnon, 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Patterns of factor prophylaxis in the Canadian hemophilia A population

S. Israels, V. Blanchette, A. Stain, 2003 .